Trial intelligence / Profile preview

Tadalafil for Treatment of Acute Urinary Retention

IRCT2017041833506N1Phase 3Completed

Sponsor
Sabzevar University of Medical Sciences
Start
Sep 2016
Modality
Small Molecules
Countries
1
01

Overview

Phase 3 trial of tadalafil in acute urinary retention, sponsored by Sabzevar University of Medical Sciences. Started Sep 2016; status: completed.

02

Drugs

tadalafil
03

Conditions

acute urinary retention

Beyond the preview

Go deeper on IRCT2017041833506N1.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on IRCT2017041833506N1.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call